Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP - Finance | November 07, 2016 | November 10, 2016 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date November 07, 2016 · Filed November 10, 2016
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 110,167 |
Ending reported balance
After 2016-11-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2016-11-07 · Exercise / conversion · Acquired 20,000 · Balance 121,905 Row 2 · 2016-11-07 · Tax withholding · Disposed 11,738 · Balance 110,167 |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $22.95 · Expires 2022-02-08 | Direct | 0 |
Reported balance
After 2016-11-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2016-11-07 · Exercise / conversion · Disposed 10,000 · Balance 0 F1: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. |
| Stock Appreciation RightSEC Table II · derivative / convertible security · Conversion / exercise price $22.95 · Expires 2022-02-08 | Direct | 20,000 |
Reported balance
After 2016-11-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2016-11-07 · Exercise / conversion · Disposed 10,000 · Balance 20,000 F2: The stock appreciation right vested in four equal annual installments beginning on February 8, 2013. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets.
F2: The stock appreciation right vested in four equal annual installments beginning on February 8, 2013.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 07, 2016 Filed Nov 10, 2016 02:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-16-149194 · doc4.xml · derivative · entry 4 ANDERSON DAVID GWIN · CIK 0001218259 · SVP - Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation right vested in four equal annual installments beginning on February 8, 2013. Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 02:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 10,000 | $0.00 Strike: $22.95 | $0.00 |
DisclosureSEC source: 0001209191-16-149194 · doc4.xml · derivative · entry 3 ANDERSON DAVID GWIN · CIK 0001218259 · SVP - Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2022-02-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the achievement of certain annual EBITDA performance targets. Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 02:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 11,738 | $79.62 | $934,579.56 |
DisclosureSEC source: 0001209191-16-149194 · doc4.xml · nonDerivative · entry 2 ANDERSON DAVID GWIN · CIK 0001218259 · SVP - Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,167 Read SEC document |
| November 07, 2016 Filed Nov 10, 2016 02:07 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 20,000 | $22.95 | $459,000.00 |
DisclosureSEC source: 0001209191-16-149194 · doc4.xml · nonDerivative · entry 1 ANDERSON DAVID GWIN · CIK 0001218259 · SVP - Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,905 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.